Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.11 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Sangamo Therapeutics (SGMOQ) Cost of Revenue (2017 - 2018)

Updated

Analysis

Sangamo Therapeutics (SGMOQ) Cost of Revenue (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.29 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.03 Bn
10 Sangamo Therapeutics 45.57 Mn -70.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 26.69 Mn
Sep 30, 2018 23.54 Mn
Jun 30, 2018 21.29 Mn
Dec 31, 2017 12.92 Mn
Sep 30, 2017 11.76 Mn
Jun 30, 2017 7.98 Mn
API Access

Sangamo Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY